Tag Archives: management

Biotech Weekly: Position Management And What To Do When You’re In The Red

If a stock that you like drops even though the thesis for holding the stock has not been altered, consider it as an opportunity to add on weakness. BLUE presented a textbook example on Friday of when to add to a position when a stock is acting weak even though the bull thesis remains unchanged. Roka Biosciences may come in with weak Q2 earnings, which would be a great buying opportunity as the thesis is built on H2 sales momentum with the improved listeria assay. Completing thorough due diligence before buying allows you to properly manage your position and provides you the conviction to add to your position on weakness. Welcome to this week’s edition of Biotech Weekly. The past week was rough for biotech investors with the iShares NASDAQ Biotechnology ETF (NASDAQ: IBB ) declining 3.6% and the more small cap SPDR Biotech ETF (NYSEARCA: XBI ) dropping 7.1%. With the rough action, both the IBB (-0.1%) and the XBI (-6.0%) are now down for the quarter, though its important to note that they are both still up significantly year-to-date. XBI data by YCharts With the recent volatility in both small and mid cap names, I’ve seen a number of biotech investors discussing making changes to their portfolios based on the profit/loss of their holdings. While I understand how it can be extremely frustrating to be underwater in a position, it is not smart or logical to make changes to your portfolio based on your unrealized gain/loss, with the one exception being strategic tax-loss trading near the end of the year. While unrealized gain/loss is a measure of how much you have lost or gained in market value since your original investment, it is not a pertinent statistic when considering the proper valuation of a security. I want to use this piece to discuss some of what I believe are important things to consider during the life of a holding and run through a few examples. When You Buy A Stock: By the time you purchase a stock, you should have completed the following tasks: Significant due diligence Review of pipeline assets and science supporting development Identification of near-term catalysts Research on the management team Consideration of the major investors in the stock Acknowledgement of companies with potentially competing treatments Thorough review of upside/downside depending on potential upcoming news Study of the capital structure Examination of the financial statements Understanding of cash runway Determining what the appropriate valuation is for the asset Thesis: From considering these factors above, you should be able to develop a thesis that explains your reasoning for holding the stock. This thesis should cover your belief why the stock will appreciate in value. Example #1: Roka Biosciences (NASDAQ: ROKA ): Back in November 2014, I looked into Roka Biosciences in some detail, but had concluded that it would be best to wait on the sidelines for another earnings report or two given that issues with false positives from the company’s Atlas Listeria LSP Detection Assay would hamper sales. After continuing to watch newsflow surrounding the company, seven months later at the end of June 2015, I highlighted Roka as a top name to buy and presented the following thesis: Pent-up sales demand for the company’s improved listeria assay projected to be cleared in July would fuel sales growth in H2 for this company trading under cash as of its last report with a solid management team and high institutional ownership that has held the stock during past weakness. Example #2: bluebird bio, Inc. (NASDAQ: BLUE ): For the second example, I wanted to present a more mainstream biotech that has experienced some recent significant volatility. Let’s discuss the example of an investor that purchased bluebird on June 24 at $170, the day after the company announced strong pricing for its common stock offering. Let’s present the following thesis that is probably similar to what many investors in bluebird believe: This gene therapy leader with a cash runway into 2018, has an exciting asset in LentiGlobin with two compelling indications (beta-thalassemia major and severe sickle cell disease) and potential data for both indications in December at ASH, an additional late-stage asset in Lenti-D, and numerous immuno-oncology collaborations likely to provide increased newsflow in 2016 presents the opportunity to invest in a new wave of technology progressing towards commercialization. Evaluating Your Position: Managing your position isn’t something that ends after you make a purchase. As an investor, your job has only begun. You are responsible for tracking how newsflow may affect the company and your thesis. If an event happens to disprove your thesis, you likely should be selling out and moving on. If the stock hits what you believe is the fair valuation and no longer presents an attractive risk/reward, you should be reducing/selling your position. Even if the stock has rallied a lot yet still presents a respectable valuation, there is nothing wrong with taking a little bit off the table, as no one has been hurt by taking a little profit. If the stock declines and your thesis remains intact, you should be adding to your position, not dumping your stock (“puking up” your position as traders say). I’ve never been a huge fan of stop losses as they can cause you to sell a stock in a market correction (such as what biotech has been experiencing recently) just because investors are going “risk-off” and not because of any company-specific news. Let’s walk through the two examples. Example #1: Roka Biosciences: Since buying ROKA in mid June, I saw the stock rise approximately 36% into a mid July announcement that the company had indeed received AOAC clearance for its improved listeria assay . I did not trim any of my position off over $3.50, as I firmly believe the stock has substantially more upside than this once the pent-up sales demand is released. I believe the stock has a good chance to return to the $8+ price per share levels where it traded before issues with false positives for its original listeria assay. When I saw the stock fade over the next few weeks, I asked myself if my thesis was still intact. After review, I determined that my thesis was indeed still intact, and the investment was actually derisked slightly given that the company had achieved the AOAC clearance. Given this, I decided to purchase more shares this month. That being said, I have been very clear that I expect Q2 sales to be poor. I started my position before Q2 earnings as I felt the current depressed valuation around cash levels, the AOAC clearance catalyst, and the potential for H2 sales momentum would provide some support and allow me to participate in upside if the company is indeed able to pull a rabbit out of its hat in terms of sales progress in Q2. Should shares drop on weak Q2 earnings, my thesis will remain intact, and this drop would be a great (and potentially last) buying opportunity. Example #2: bluebird bio, Inc.: After bouncing around between $155 and $170 per share after the offering, the stock declined from a high of $168.03 on August 6 to a low of $129.01 only a day later. So, what caused the stock to tank more than 23% in this short period of time? The company had provided its second quarter operating results in a press release on August 6 , but there wasn’t anything particular of note. The thesis I presented above remained fully intact. Selling merely appeared related to a risk-off theme of selling every biotech in sight, especially if they did not have a major catalyst this quarter. There’s no reason to sell the stock just because your profit/loss line in your account now shows you at a loss. An investor that had bought the stock after the most recent offering given the thesis I presented would certainly have been downright confused by the significant drop, but should have taken the drop as a gift and added to the bluebird position. Many investors certainly realized that the stock was being inappropriately beaten down as it proceeded to rally over 25 points in a half-day of trading. What type of stock has a 25-point intraday rally in a weak market? A stock that shouldn’t have been receiving a beating in the first place. Who was selling bluebird below 140? It certainly didn’t make sense for me. Those that had bought recently should have been adding if anything as their investment thesis likely remained intact. Those that bought the stock much lower should have been selling in the $160-170 range if they felt the stock was fairly valued, not dumping shares after a decline over 20% after parts of two trading days. Conclusion: Don’t jump into stocks until completing thorough due diligence. This through due diligence allows you to properly manage your position. Make sure to develop a solid thesis, which you can see play out by tracking newsflow. If a stock that you like and believe presents a reasonable valuation drops even though the thesis for holding the stock has not been altered (as we saw with bluebird on Friday), consider this an opportunity to add to your position on weakness, not blindly dump your shares as the stock declines for no significant company-specific reason Editor’s Note: This article covers one or more stocks trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks. Disclosure: I am/we are long ROKA. (More…) I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Revisiting The 100 Stocks With The Lowest Volatility In S&P 500 Index

Summary We expand the discussion from a recent Editor’s Pick on building portfolios with the lowest volatility stocks in the S&P 500 Index. We point out that high beta is not necessarily high momentum and discuss why low volatility stocks might provide stronger performance. We simulate the portfolio construction calculations behind the S&P 500 Low Volatility Index and construct the current Top-10 portfolio holdings. We re-rank the lowest volatility stocks by momentum metrics to find stocks trending higher even in the current choppy market conditions. Introduction In a recent Editor’s Pick , Ploutos discussed the relative merits of using low volatility and high beta funds to generate better returns than the SPX (Ref 1). He combined the PowerShares S&P 500 Low Volatility Portfolio (NYSEARCA: SPLV ) and the PowerShares S&P 500 High Beta portfolio (NYSEARCA: SPHB ) to improve returns. His analysis is open to two criticisms. First, he was using a high beta portfolio as a substitute for a momentum strategy. However, high beta does not necessarily mean high momentum. Naturally, these terms are not cast in stone, and differences in calculation methodology and time period of data used in the analysis can change the measured beta as well as calculated momentum. So, for example, a fund like the PowerShares DWA Momentum Portfolio (NYSEARCA: PDP ) could be substituted for the SPHB portfolio. Second, he does not discuss why a stock may have low volatility, why a group of 100 stocks with the lowest volatility had returns greater than the full 500-strong index, and why this outperformance should persist for years on end. Thus, it is theoretically possible to go through a prolonged period during which the 100 stocks with the lowest volatility as a group do not consistently outperform the full index or their high-beta cousins quarter after quarter, and two groups flip flop back and forth negating any benefit of switching from one group to another. Why do stocks have low volatility? There are many reasons a stock could have low volatility. A stock may have low volatility because it has slow earnings growth and does not have the price amplitude, volume and spreads to catch the fancy of short-term traders. The stock may have large institutional ownership, and any dip in the stock leads to greater accumulation by institutions, so that large drops are rare. The earnings could be highly predictable and consistent, so the stock does not produce either positive or negative earnings surprises. The stock could have a large dividend payout, so it trades more like a bond than a stock. The stock could have gone through a period of very high volatility, that has shaken “weak longs” out of the stock, and volatility has diminished as the stock goes through a consolidation. A stock may be viewed as having a conservative management with high cash-flow, slow-growth businesses, that are not sensitive to strength or weakness in the economy. Hence, low volatility could be proxy for slow growth, high cash generators with large institutional ownership that are perceived as “low risk” investments. Thus, the exact reasons that a stock has low volatility over a given period and its implications for price advancement over the immediate future are unclear. Also, there could be numerous other reasons for low volatility in a stock. Why do low volatility stocks outperform the full index? In the ideal scenario, a stock has low volatility, is accumulated, and volatility increases due to favorable developments in the stock, such as improved growth prospects, and the stock breaks out into a strong trend. For example, management could focus on cutting costs and buying other companies with higher-margin products in the same sector. Thus, trading low volatility becomes a counter-trend entry into a stock that will morph into a growth story in the future. In this scenario, this stock starts off as a low volatility entity that shifts gears into a high growth phase, accounting for its outperformance. Of course, it will eventually drop off the 100-lowest volatility list, but then, its substitute will ideally repeat the same pattern. Alternately, the external market environment deteriorates, due to a weak economy or geo-political risks, prospects for price acceleration are murky or confusing, and money comes out of high-beta or high-volatility stocks and rotates into low-volatility stocks, being used as a temporary hedge or defensive position against market worries. These conditions could last for several quarters, and would again account for out-performance versus the full index. Naturally, there could many other possibilities for why low volatility stocks perform better than the index as a whole, such as buy-outs, rising dividends or a prolonged period of very low interest rates. Current State of Play: SPLV ETF As we have discussed above, low volatility does not have to mean low returns, especially when these stocks are used as a bulwark against market uncertainty. We perform a full trend analysis of the top-10 holdings of the PowerShares SPLV ETF (see Figure 1) below. The Top 10 are trending well, with good buying support for CB and BAX in particular. (click to enlarge) Figure 1: The current Top-10 holdings in the SPLV ETF are trending well given all the uncertainty in the market. (Data courtesy ETFmeter.com ) Updated Holdings through August 6 We asked the question: what would the current top 10 look like? We copied the methodology of the index and our updated top-10 holdings are shown in Figure 2. From Figure 1, XL Company (NYSE: XL ) and Stericyle (NASDAQ: SRCL ) are the only two companies in the top 10. One can then argue that an equally weighted portfolio would be better, since the rebalancing would only involve stocks which dropped out of the 100 least volatile stocks group. Figure 2: We update the portfolio weights using data through August 06 and the methodology described by the index provider. Only two of stocks, XL and Stericycle from the current top-10 in the SPLV ETF are on the list. (Data courtesy ETFmeter.com) The Best Trending of the 100 Lowest Volatility Stocks We can now ask the question: which are the best trending of the 100 stocks with the lowest volatility in the S&P 500 index? How are they doing? If money is rotating into low-volatility stocks in the face of market worries, then the 10 best trending stocks out of the 100 stocks with the lowest volatility in the S&P 500 index should be largely defensive stocks with steady earnings. We check this hypothesis in Figure 2 below using data through August, 06 2015. We find that out of the lowest 100 stocks, seventeen stocks seem to be surging, and we show them in Figure 3. The charts are somewhat similar, and we show the charts of Kellogg (NYSE: K ) and Clorox (NYSE: CLX ) to illustrate this idea (see Figures 4 and 5). Figure 3: The 17 stocks with the strongest trends in the 100 stocks with the lowest volatility in the S&P 500 index are a who’s who of defensive stocks. (Data courtesy ETFmeter.com) (click to enlarge) Figure 4: The Kellogg chart is rising strongly during the recent market uncertainty after analyst upgrades. (Chart courtesy StockCharts.com) (click to enlarge) Figure 5: The chart for Clorox looks quite similar to the one in Figure 4, showing the defensive rotation into low volatility stocks. (Chart courtesy StockCharts.com) Summary The low volatility group in the S&P 500 index can offer a respite in the rough seas of a choppy market. There are many alternatives to constructing portfolios with the lowest 100 volatility stocks and combining them with high beta and pure momentum strategies. Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. (More…) I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.

Vectren’s (VVC) CEO Carl Chapman on Q2 2015 Results – Earnings Call Transcript

Vectren Corp (NYSE: VVC ) Q2 2015 Results Earnings Conference Call August 06, 2015, 11:00 AM ET Executives Naveed Mughal – IR, Treasurer Carl Chapman – CEO Susan Hardwick – CFO Analysts Matt Tucker – KeyBanc Capital Markets Paul Patterson – Glenrock Associates Operator Good morning. My name is Jessica and I’ll be your conference operator today. At this time, I would like to welcome everyone to the Vectren Corporation’s Second Quarter 2015 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session. [Operator Instructions] I would now like to turn the call over to Naveed Mughal, Treasurer and Vice President of Investor Relations. Mr. Mughal, you may begin your conference. Naveed Mughal Thank you, Operator. Good morning and thank you for joining us on today’s call to review Vectren’s 2015 second quarter results. This call is being webcast and shortly following its conclusion, a replay will be available on our website at www.vectren.com under the Investors link at the top of the page. Yesterday, we released our second quarter results and this morning we filed our Form 10-Q with the SEC. Under the Investors link on our website, you can find copies of the earnings release, today’s slide presentation and the 10-Q. As further described on Slide 2, I would like to remind you that many of the statements we make on this call are forward-looking statements. Actual results may differ materially from those discussed in this presentation. Carl Chapman, Vectren’s Chairman, President and CEO, will provide opening comments on the quarter’s financial results and our outlook for the remainder of the year. He will then turn it over to Susan Hardwick, Senior Vice President and CFO, who will discuss in more detail our utility and non-utility results. Lastly, joining us on today’s call is Ron Christian, Executive Vice President and Chief Legal and External Affairs Officer. Following our prepared remarks, we will be glad to answer questions you may have. With that, I’ll turn it over to Carl. Carl Chapman Thank you, Naveed. And before we go further, I’d like to officially welcome Naveed to Vectren and our management team since this is his first earnings call with us. For those of you who don’t know, Naveed joined as our new Treasurer and Vice President of Investor Relation just a few weeks ago. He comes to us from NV Energy, where he most recently held the Treasurer position. Naveed’s recent utility industry experience combined with his extensive treasury experience adding prior to NV Energy should make for a smooth transition. Naveed, welcome. I’d also like to wish our outgoing Treasurer and colleague, Robert Goocher, the best in his recent retirement, which began just a few days ago. Robert was an integral part of our successful navigation of the capital markets over the past 13 years. We thank Robert for all he has done for Vectren. With that, let’s turn to Slides 4 and 5 as we begin our review of second quarter results. I’d like to remind everyone we have excluded the 2014 results of coal mining, specifically the $0.23 loss in the 2014 second quarter results related to the exit. You will find a reconciliation of GAAP and non-GAAP measures at the end of the appendix. 2015 second quarter consolidated net income was $35.8 million or $0.43 per share compared to $30.1 million or $0.37 per share in 2014. In the quarter, we continued to see earnings growth anchored by solid utility results that achieved second quarter earnings per share of $0.29, an increase of $0.01 over 2014. In addition, improved results from both Vectren Infrastructure Services and Vectren Energy Services, which were both slightly better than expected, allowed the non-utility group to earn $0.14 per share in the second quarter, up $0.05 compared to the prior year. Utility performance year-to-date and for the quarter has been strong and the outlook is positive for the remainder of the year as return on the investment in new gas infrastructure continues to grow. In addition, the economic environment in Indiana and Ohio remains positive with June unemployment rates of 4.9% in Indiana and 5.2% in Ohio, both below the national rate of 5.3%. At Vectren Energy Services results for the quarter, while a slight loss, were improved over the prior year. Revenues for the quarter were $44 million compared to $33 million in the same period last year and $23 million in the first quarter of 2015. For the quarter, VESCO saw new contract signings totaling $53 million compared to $34 million in the prior year. In addition, on August 5, a large contract with NASA’s Johnson Space Center was signed, which as expected will be significant to VESCO’s third quarter and second half results. Also in the second quarter, Vectren Infrastructure Services achieved improved results that were up $2.9 million over the prior year driven by very strong demand for construction work in the gas distribution market. However, competition in the transmission market has put some margin pressure on VISCO’s expected second half results, which Susan will describe in greater detail. Overall, based on the continued strength of our utility outlook, we are affirming our 2015 consolidated earnings per share guidance of $2.40 to $2.55, while there are headwinds facing VISCO over the remainder of the year that could pressure us toward the lower end of the guidance range. We have full confidence in VISCO’s leadership team and therefore our ability to manage through these market conditions. Turning to Slide 6. I’d like to reiterate our long-term targets that we announced last November. We have been executing on our strategy for several years now which has led to a track record of earnings growth that we believe will continue into the future. On the utility side, we have approvals in place for gas utility infrastructure investments and a framework for current recovery of those investments. Company-wide, we’ve created a culture of performance management that focuses on limiting operating cost increases. And on the non-utility side, we have concentrated our efforts on our strategic investments in VISCO and VESCO. In the graph on the bottom left, one I’m sure you’ve seen before and we’ll see again as we’re quite proud of it. You can see over the past several years, we’ve put Vectren in a position to have achieved higher, more reliable and consistent consolidated earnings growth. As we work through the exit of nonstrategic businesses and kept our annual dividend increases modest, we were able to drive the payout ratio down from roughly 80% toward our new target of 60%. All this positioned us to roll out new long-term targets last November that are shown on the right, the primary ones being the consolidated earnings and dividend growth targets of 5% to 7%. Of course aligning the two provides the foundation to deliver the shareholders of total return target of 9% to 11%. In conjunction with the lower payout ratio and these new growth targets, last November we announced a dividend increase of $0.02 per share or 5.6%. This was the largest dividend increase for Vectren or its predecessor since the early 1990s and extended our streak to 55 consecutive years of increasing the dividends paid. And as we said in November and I want to make clear, we expect the annual dividend to grow with our earnings also at 5% to 7%. With that review of the overall story of Vectren which, we believe, compares very favorably to our peers, I’ll turn it over to Susan who will provide more detail on each of our business’ results for the quarter and outlook for the rest of the year before we open it up for questions. Susan? Susan Hardwick Thanks, Carl. Let’s turn to Slide 7 where we’ll start with the utility. Improved utility results for the quarter were driven by higher returns from gas infrastructure investments in both the Indiana and Ohio and lower O&M related to performance-based compensation expense. These were partially offset by decreased margin from wholesale power sales. On the regulatory front, we continue to see support for our approach to infrastructure investments and recovery. In June, the Indiana Court of Appeals found in our favor on the appeal by the Utility Consumer Counselor to the single item in the Commission’s order issued in August 2014 approving Vectren’s initial infrastructure plan under Senate Bills 560 and 251. On April 1, Vectren filed its second request for recovery of investment related to our gas infrastructure plan in Indiana, something we’ll do semi-annually throughout the seven-year plan period. And then in June, we amended our case to delay the recovery of a portion of the investment made in the second half of 2014 related to approval through Senate Bill 560 under our next filing in October — until our next filing in October of this year. We did that because of the recent activity around these types of filings in the state and to ensure that we had sufficient opportunity to include the appropriate level of detail regarding the projects in our filings, which will expedite the Commission’s and other party’s review. In July, the Commission issued an order that substantially approved our approach to rate recovery of our investments. The Commission also agreed with our approach to address in our October filing the consideration of whether enhancements to our seven-year plan relating to the sufficiency of the project and cost details will be appropriate. The Commission did make one modification in this order requiring that we use an updated weighted cost of capital in each filing. We do not view this as a material change and to be expected the Commission continue to work through implementation of this new law. With these Commission orders in place, Vectren expects to continue with this gas infrastructure program and investments as planned. Finally, as you all know, on August 3, EPA issued the final rule under the clean power plan. We’re currently evaluating the rule including the reduction goals and how the plan might impact our customers and we’ll work with the State of Indiana on its response to this action. For any investments required to comply with these goals, as always, we will consider the cost implications for our customers since we would expect timely recovery under Senate Bill 251 related to federal mandates or Senate Bill 29 related to clean coal. Turning to Slide 8. As Karl mentioned, Vectren Energy Services’ second quarter results were improved over the prior year, of $0.4 million. This included solid increases in revenues and new contracts signed versus the 2014 period reflecting continued positive momentum. I’m also pleased to report that VESCO has now signed contracts for the three major projects we referenced in May totaling nearly $80 million, one of which I’ll describe further in just a minute. Because of VESCO’S continued success with contract signings in the quarter, backlog has again increased versus the prior quarter end. At June 30, backlog was $175 million compared to $161 million at March 31 and $144 million at December 31, 2014. In addition, as Carl mentioned earlier, VESCO secured a large contract with NASA’s Johnson Space Center just yesterday. The project’s objective is to maximize energy cost savings by constructing a new combined heating power plant and making improvements to a chilled water plant. The contract includes the construction cost of approximately $47 million that will be added to backlog now that the contract is fully executed. The contract also includes a 22-year operations and maintenance agreement. The sales funnel, which includes contracts that have been awarded, but are not yet signed, remains very high at over $360 million as of June 30 even with the significant project signings in the second quarter. As we described previously, one of the biggest obstacles VESCO faces is the length of time it takes customers to sign contracts on projects that have already been awarded. VESCO continues to work to improve the sales cycle process including the standardization of procedures and timelines for project procurement, documentation and implementation. In June of this year, the Energy Services Coalition, which is one of the two primary trade associations for the energy services industry and has been led by one of our colleagues here at Vectren, was awarded a three-year contract with the US Department of Energy that includes funding for multiple initiatives to help accelerate the successful implementation of energy savings performance contracting, including sales cycle efficiency improvement. The DOE’s aim for funding the Energy Services Coalition is to have it lead outreach programs and provide technical assistance to states helping them build capacity for performance contracting initiatives and improve project procurement processes and timeline. We think this is yet another step in helping to improve the timeliness of this process. Let’s move onto Slide 9. Vectren Infrastructure Services had an excellent second quarter, improving earnings $2.9 million over the prior year. Year-to-date results are up more than $5.5 million compared to last year. And similar to the first quarter, demand for construction services was strong as VISCO achieved record second quarter revenue levels, which were $53 million higher than the same period in 2014. Earnings from operations in the second quarter were up more than $5 million over last year, driven largely by working the distribution market including work done by A&B Trenching. As you recall, A&B was acquired in May of this year and has performed well and as planned. The outlook for VISCO, second half of the year looks promising from a demand and revenue standpoint. Estimated backlog remains strong at approximately $575 million as of June 30, down slightly compared to $610 million at March 31. On the distribution side of the business, we have continued to add workers and expect to continue to significantly outpace 2014 revenues this year, as demand from utilities continues to grow. The record second quarter revenues contributed somewhat to the decline in June 30 backlog, but also VISCO was unsuccessful in a bid for significant transmission maintenance work that was included in the recent backlog. They had expected to perform this work in the second half of 2015. The VISCO team is diligently working to replace this loss of business and the prospects to do so are very good, but it is possible the margins for new projects may be lower than the maintenance work that was planned and therefore may result in pressure towards the lower end of our original 2015 earnings expectations for VISCO. However with significant projects announced and plans to start in mid-2016, our ability to grow the transmission business in 2016 and beyond should not be significantly impacted as market demand is expected to be very high over the next few years. Turning to Slide 10, here are just a few key drivers of our positive outlook. First, utility earnings will continue to grow as we execute detailed investment plans with approved recovery mechanisms in both Indiana and Ohio. Vectren Energy Services’ earnings prospects continue to strengthen as the national focus on energy conservation, renewable energy and sustainability expands given the widespread attention and expected rise in power prices across the country. VESCO is well-positioned to compete in all three market segments; federal, public sector and sustainable infrastructure. And finally, Vectren Infrastructure Services is well-positioned to compete for market share demand continues to grow from the newly announced distribution replacement programs, additional federal pipeline regulations likely to come, and while we and others expect to be very high market demand for transmission projects for which construction will begin in mid-2016 through 2018. Concluding on Slide 11. I want to reiterate our belief that Vectren merits premium valuation consideration. We have worked to position the Company to deliver greater stability and higher consistent earnings growth. The utility remains our core business having demonstrated a very strong track record of earnings has allowed returns. Gas infrastructure investments backed by approved recovery plans will continue to be the growth engine, driving utility earnings growth targeted at 4% to 6%. These investments will also drive it in the relatively near-term to being a predominantly gas utility from an earnings perspective and therefore deserving a more gas-like multiples. And complementing our premier utility operations is our high-quality, non-utility business mix with the growth driven by long-term demand for infrastructure investments, energy efficiency and sustainable infrastructure across the nation. Based on our EPS guidance and expectations, our streak of several years of consistent earnings growth should continue in 2015. While we fully expect to be in the range even at the very low end of our EPS guidance range of $2.40 per share, we would still see growth of 5.3% compared to 2014. So, in conclusion, our 5% to 7% earnings and dividend growth targets, coupled with our 60% payout target and a 55-year history of growing dividends, serve us strong anchors for our annual total shareholder return target of 9% to 11%. We are very confident in our ability to deliver on all of these targets. And with that, operator, we are now ready for questions. Question-and-Answer Session Operator [Operator Instructions] Your first question comes from Matt Tucker with KeyBanc Capital Markets. Your line is now open. Matt Tucker Good morning and nice quarter. Few questions, first on VISCO, could you give us a sense of how much transmission represents right now in terms of your revenue or backlog mix? Carl Chapman Yes, Matt, as you know, we really don’t give a split on distribution and transmission. We certainly have indicated the distribution has been growing very nicely and we did have the one maintenance work that we didn’t retain. So, that put it in a perspective for you, but in terms of a split, this is not something that we provide. Matt Tucker Fair enough. And when you talk about transmission, is that mostly with non-utility customers, non LDCs? Carl Chapman Yes. I think that when we talk about distribution, that’s really the LDCs. And as we suggested, that actually has been growing faster than we expected. And so when we talk about transmission, it is going to be either big pie first of all gas or oil. It could be liquids, you know, other kinds of liquids, but it’s mostly going to be gas or oil. Matt Tucker Got it. So, looking at your current backlog now, how much, if any, do you view as being at risk due to competition like what you saw with this [indiscernible]? Carl Chapman Well, obviously, we would not describe it as backlog if we had great concern about it. We try to always acknowledge that our backlog numbers are estimates, we describe in our appendix with our metrics, we describe how we come up with the backlog, and so we always want to make sure that everyone understand that is an estimate, but on the other hand, it is a well thought-out estimate and we feel very good about the numbers we are sharing. Matt Tucker One other follow-up to that. I noticed the mix shift in the backlog moved fairly significantly toward bid work away from blanket contracts more than just at $35 million that you mentioned. Any color you can provide on what’s going on with that mix shift? Carl Chapman I don’t think there is a whole lot to add. We tried to share in our discussion and in our comments that we are seeing by our customers a greater desire for bid kind of contracts, so I think there’s just a bit of a change in the market right now. We’re not prepared to say that’s a permanent change, particularly when we see the additional work, but we’d just have to monitor and see how that unfolds. There’s still a lot of work being done under blanket. Matt Tucker Okay, thanks. And then just one more from me. I noticed in your first quarter slides, you provided the guidance metrics for the non-utility businesses that you provided earlier in the year, I don’t see that in the slides today, should we consider that guidance stale at this point or do they just like not have space to put it on the slide or something? Carl Chapman I think that what we did say is we focused on the consolidated, I don’t know that we consider it stale, we just don’t have any reason to provide it again, but we feel pretty good again by acknowledging and confirming our original guidance, we feel pretty good about the pieces of it. Matt Tucker Okay. Thanks, Carl. Carl Chapman Thank you. Operator [Operator Instructions] Your next question comes from Paul Patterson with Glenrock Associates. Your line is now open. Paul Patterson Good morning. So, just to follow up on Matt’s question on the backlog. What would happen if you would just for accounting backlog from contracts that were actually awarded versus your estimation of bid. I mean, is that a possibility to serve the idea of just maybe estimating your backlog on what exactly was awarded as opposed to your estimation of what was bid and what, you think, will be awarded? Carl Chapman Yes, I think we covered this in prior calls and even when we came out with the backlog, the reality is that you never can do that with blankets and there’s a pretty significant portion of the backlog, or it could be in blanket, it may vary quarter-by-quarter or at any point of time how much is the bid approach versus the blanket approach, but I think that you know it’s going to always be an estimate. So, I don’t think that we have a need to provide any more detail in that regard because what we’re trying to do with backlog is give you a sense of what’s going on out there in terms of what’s the business look like and clearly there’s lots of bidding going on. So, there’s plenty of opportunity, which we tried to share, we’ve seen no slowdown in the opportunities and so we feel like it’s the best backlog approach that we can provide. We certainly have debated that over time. I think we’re pretty comfortable. This is the best approach to give you a real sense where the business is going. Paul Patterson Okay. And then just in terms of the competitive environment that you guys described, any outlook on that and how that might work, do you see any potential shakeout or do you see it increasing, due you see more accompanying, do you see potential for the competitive levels to increase or just any outlook you might have with respect to that? Carl Chapman Sure. Well, the first thing I’d say is that we really are sitting here and talking about this because we lost a certain amount of work. We are not seeing tons of changes, but what happens is that it’s a mix of work issue. So, now we are looking at additional mix of work, we’re not going to change our risk profile what we’re willing to look at, in anyway, we won’t take additional risk if you will, but there is a change in the mix of the work and that really drives this margin issue as much as anything. And I also believe that because the industry does see such a strong, call it, the mid-2016, but sometime in 2016 to 2018 see such a strong amount of work that’s been announced, I think you see a lot of people making sure that they’re positioned well for that and that has an impact on margin as you try to make sure that you’ve got your people and make sure you’re positioned when that pick-up occurs in a very big way. Paul Patterson So in other words, you will see margins improving in 2016. Carl Chapman Well, I don’t know that we’re prepared to say they’re going to improve. We’ll have to monitor them and see. I certainly think they have the potential to do that, but we’ll have to see how the competition reacts. Paul Patterson Okay. I appreciate it. Thank you very much. Operator [Operator Instructions] And your next question comes from Matt Tucker with KeyBanc Capital Markets. Your line is now open. Matt Tucker Just a couple of questions on VESCO now, congrats on the NASA contract by the way, of the $80 million large contracts you mentioned that have now been booked and I assume the NASA was part of that, was the rest booked in the second quarter? Carl Chapman Yes. What we did there is we would’ve loved it if NASA had gotten signed on June 30, just a little bit later than that, but what we shared at the end of the last quarter was those three contracts totaling $80 million would get signed and they now are signed. Yes, NASA was just a little later than we would have preferred, so the other two were signed as well as other contracts of course, but what we really wanted to demonstrate there was the business is doing what we said it would do, and those contracts were signed and they are working on. Matt Tucker And then with respect to the sales funnel and like the $360 million, are there other large projects in a similar size to this, and then it was thought that or have you seen any change in the duration of the sales cycle? Carl Chapman Well, I think Susan went through in some detail, some of the work that’s being done and I think that we do feel better about the sales cycle, what will happen to us at times, particularly in a large contract, it’s that one contract we want to try to give some transparency on and it may turn out to be much longer timeframe. That obviously happened with the NASA contract, but I think we are seeing some positive signs in terms of the sales cycle. And I think we’ll continue to focus on that. As Susan described, we had some deal with E-dollars provided to one of the trade agencies. In terms of the funnel itself, I don’t think that the funnel is unusual at all in its make-up right now. There certainly are some large contracts and a lot of small contracts and we feel pretty good about where that funnel is at this point as we try to move those to signing. Matt Tucker Thanks, Carl, that’s helpful. And then actually just one more on VISCO. You mentioned the PHMSA rules potentially driving increased customer spending. Could you expand a little bit on that? Susan Hardwick Yes. I think, Matt, let me make just a couple of comments and Carl certainly can way in here too. We think the rules that have been finalized in 2015 really were more administrative in nature, didn’t have a whole lot of impact on us. We do believe there are some additional rules yet to come around operating pressures and vales and inline inspection work. There could very well be some implications for everybody that does this type of work, but in our particular case, we feel like we again are well-positioned. We’ve been doing a number of these procedures for some time and have many of those proposed or expected requirements built in our plans already. So, again, the expected implications to us should be hopefully pretty insignificant once the rules come out. Again, that’s based on our current view of what those rules are likely to evolve into and again that could change, but we, again, feel pretty strongly about our plans and how we’ve developed our plans around those expected requirements. Carl Chapman And as Susan mentioned, if those opportunities are to be greater, obviously we’ll work with our regulators and have opportunity in our utility, but also of course that’s a real positive for Miller and I don’t mean related to our utilities, but across the country, other utilities would be doing that additional work if it turns out that way. Matt Tucker Makes sense. Thanks, Carl. Thanks, Susan. That’s all I had. Carl Chapman Thank you. Operator Now, we have no further questions at this time. I’ll turn the call back over to the presenters. Naveed Mughal I’d like to thank everyone for joining us on the call today. I look forward to meeting many of you over the coming months. On behalf of our entire team, we appreciate your continued interest in Vectren. With that, we’ll conclude our call for today. Thanks again for your participation. Operator This concludes today’s conference call. You may now disconnect. Copyright policy: All transcripts on this site are the copyright of Seeking Alpha. However, we view them as an important resource for bloggers and journalists, and are excited to contribute to the democratization of financial information on the Internet. (Until now investors have had to pay thousands of dollars in subscription fees for transcripts.) So our reproduction policy is as follows: You may quote up to 400 words of any transcript on the condition that you attribute the transcript to Seeking Alpha and either link to the original transcript or to www.SeekingAlpha.com. All other use is prohibited. THE INFORMATION CONTAINED HERE IS A TEXTUAL REPRESENTATION OF THE APPLICABLE COMPANY’S CONFERENCE CALL, CONFERENCE PRESENTATION OR OTHER AUDIO PRESENTATION, AND WHILE EFFORTS ARE MADE TO PROVIDE AN ACCURATE TRANSCRIPTION, THERE MAY BE MATERIAL ERRORS, OMISSIONS, OR INACCURACIES IN THE REPORTING OF THE SUBSTANCE OF THE AUDIO PRESENTATIONS. IN NO WAY DOES SEEKING ALPHA ASSUME ANY RESPONSIBILITY FOR ANY INVESTMENT OR OTHER DECISIONS MADE BASED UPON THE INFORMATION PROVIDED ON THIS WEB SITE OR IN ANY TRANSCRIPT. USERS ARE ADVISED TO REVIEW THE APPLICABLE COMPANY’S AUDIO PRESENTATION ITSELF AND THE APPLICABLE COMPANY’S SEC FILINGS BEFORE MAKING ANY INVESTMENT OR OTHER DECISIONS. If you have any additional questions about our online transcripts, please contact us at: transcripts@seekingalpha.com . Thank you!